PBRM1 and nonpapillary renal cell carcinoma: found that exosomal mRNA‐based (CUL9, KMT2D, PBRM1, PREX2, and SETD2) signatures may serve as tools for the early detection of ccRCC and differential diagnoses of uncertain renal masses.23